* GENEWAVE *
2001 - IDF
Palaiseau
(near Paris)
www.genewave.com Design, Devices
Key words: Automated real-time micro-array, Hybridization imaging systems, Low-cost micro-array readers, HybLive
Mission: to develop, manufacture and market cutting-edge microarray instrumentation for diagnostic, clinical and life science research
Clients: Research labs, Biotech, Other Institutions, OEM markets
info@genewave.com
Age: 8 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.-CEO: Desforges (François-Xavier) [born 1960, Ph.D. Electronics, ex-Photonetics]
Oper.Dir.-COO: Choumane (Houtaï) [Ph.D. Optics, also co-CEO]
Sc.Dir.-CSO: Weisbuch (Claude) [co-founder, born 1945, Ph.D. physics, Normale Sup, CNRS, University Professor (USA), ex-Bell Laboratories, Saint-Gobain, Thomson-CSF] and Cerovic (Gordana) [Ph.D., ex-ValiGen]
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): | Turnover (M€) : 0.31 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Trade
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2009 .06 | Financing (no interest loan) : 9.0 M€, by OSEO Innovation, for the NOSOBIO program for prevention, diagnostics and treatment of hospital-acquired infections (with Serial Genetics, Palumed, Da Volterra, Institut Pasteur and Assistance Publique-Hôpitaux de Paris) | DEBT | [7 years] |
| 2008 .05 | Launch of HybLive, first real-time micro-array platform | MKTG | [6 years] |
| 2008 .01 | Nomination : François X. Desforges as President and Houtaï Choumane as CEO | ORGN | [6 years] |
| 2001 .12 | Company founded by Claude Weisbuch (CEO), François Vallet and others | ORGF | [0 year] | Actualisation / Updating: 07-Sept-2009 |
|
